Abbott: Sequel Med Tech and Abbott to Integrate Future Glucose-Ketone Sensor with twiist AID System

What You Should Know: - Sequel Med Tech, a company developing state-of-the-art insulin delivery technologies, announced a commercial development agreement with Abbott. - The collaboration aims for the future integration of Sequel's twiist Automated Insulin Delivery (AID) System, powered by Tidepool, with Abbott's glucose-ketone sensor, which is currently under development. - The planned integration is ... Read More